Therapeutic Index
Raed D. Abughazaleh, Timothy S. Tracy · Wiley StatsRef: Statistics Reference Online · 2014
Abstract Therapeutic index is an expression of the relative toxicity as compared to efficacy of a given compound. In animal studies, it can be computed as the ratio of the median lethal dose (LD50) to the median effective dose (ED50). In humans, it is frequently expressed as the ratio of the median toxic dose (TD50) to the ED50. Several issues limit the utility of the therapeutic index, and to‐date there remains no official list of drugs considered to possess narrow therapeutic indices. Mortality is a poor measure of a drug's toxicity and raises ethical concerns in animal studies. Similarly, ED50can be a poor measure of a drug's effectiveness because of lack of consistency in endpoint biomarkers and because the ED50may be different for multiple conditions the drug may be used to treat. When LD50and ED50are obtained in animals, any extrapolation to humans is limited. In addition, multiple factors of interindividual and intraindividual variability exist in humans and can limit the utility of a therapeutic index estimate. Interindividual variability can be caused by either pharmacokinetic or pharmacodynamic differences, and may play an important role in brand‐to‐generic switching of narrow therapeutic index drugs. Intraindividual variability can also be related to physiologic factors that affect absorption, distribution, metabolism, or excretion of a drug. In conclusion, use of a therapeutic index requires an understanding of its limitations, and may be most useful in the preclinical stages of drug testing where limited experience of the drug's administration is available. To date, there remains no official guidance to research laboratories and pharmaceutical companies on the optimal use of therapeutic index.